Skip to main content

Table 3 GFR and proteinuria stages, and CKD prevalence by different equations according to 2009 KDIGO classification

From: The impact of different GFR estimating equations on the prevalence of CKD and risk groups in a Southeast Asian cohort using the new KDIGO guidelines

 

G1

G2

G3a

G3b

G4

G5

CKD ALL

CKD 3-5

CKD-EPI

27.5

60.4

9.2

2.3

0.6

0.1

19.7a

12.1a

 

25.5

1.8

0.2

54.8

5.1

0.5

7.6

1.5

0.1

1.7

0.5

0.1

0.5

0.1

0.0

0.0

0.0

0.0

  

S-MDRD

11.2

67.5

16.8

2.7

0.6

0.1

27.1a

20.2a

 

11.1

1.0

0.1

61.8

5.2

0.5

14.6

2.0

0.2

2.0

0.6

0.1

0.5

0.1

0.0

0.0

0.0

0.0

  

J-EPI

3.2

58.9

30.7

5.8

1.3

0.1

43.0a

37.9a

 

2.9

0.2

0.1

54.1

4.4

0.4

27.4

3.0

0.3

4.7

1.0

0.1

1.0

0.2

0.1

0.1

0.0

0.0

  

C-MDRD

45.6

48.9

4.0

1.3

0.2

0.05

14.2b

5.5b

 

41.7

3.5

0.4

44.1

4.4

0.4

3.1

0.8

0.1

1.0

0.2

0.1

0.2

0.0

0.0

0.0

0.0

0.0

  

T-GFR

29.2

65.5

4.3

1.1

0.1

0.04

14.0

5.4

 

27.1

1.8

0.3

58.9

6.0

0.6

3.2

1.0

0.1

0.9

0.2

0.0

0.1

0.0

0.0

0.0

0.0

0.0

  
  1. Data shown as percentages of all subjects (n-5526) for each GFR stage (G1-5) and for each proteinuria subdivision
  2. (represented as 3 subdivisions of each G stage from A1 to A2 to A3 from left to right). CKDALL CKD from stage 1 to 5, CKD3-5 CKD stages 3 to 5
  3. a CKD prevalence different compared to all other equations (p < 0.001)
  4. b CKD prevalence different to other equations (p < 0.001) except with T-GFR
  5. CKD-EPI, Chronic Kidney Disease-Epidemiology Collaboration; S-MDRD, standard MDRD; C-MDRD, Chinese MDRD; J-EPI, Japanese CKD-EPI; T-GFR, Thai GFR